Fertility and Sterility
Volume 88, Issue 2 , Pages 383-389 , August 2007

Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17β-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study

  • Camil Castelo-Branco, M.D., Ph.D.

      Affiliations

    • Institute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clinic, Faculty of Medicine–University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
    • Corresponding Author InformationReprint requests: Camil Castelo-Branco, M.D., Ph.D., Hospital Clínic i Provincial, Villarroel 170, 08036-Barcelona, Spain (FAX: 0034932279325).
    • ,
  • Santiago Palacios, M.D., Ph.D.

      Affiliations

    • Instituto Palacios, Madrid
    • ,
  • Francisco Vázquez, M.D., Ph.D.

      Affiliations

    • Clínica Centro de Estudios de Obstetricia y Ginecología Asociado (CEOGA), Lugo
    • ,
  • José Villero, M.D., Ph.D.

      Affiliations

    • Obstetrics and Gynecology Department, Hospital Universitario Córdoba, Córdoba
    • ,
  • Javier Ferrer, M.D., Ph.D.

      Affiliations

    • Gynecology and Obstetrics Department, Hospital Universitario Central de Asturias, Oviedo
    • ,
  • Carlos Ascaso, M.D., Ph.D.

      Affiliations

    • Department of Public Health, University of Barcelona, Barcelona, Spain
    • ,
  • Juan Balasch, M.D., Ph.D.

      Affiliations

    • Institute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clinic, Faculty of Medicine–University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona

Received 21 July 2006 ,Revised 27 November 2006 ,Accepted 27 November 2006.

References 

  1. Writing Group for the PEPI Trial . Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273:199–208
  2. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab. 1997;82:414–417
  3. Gambacciani M, Ciaponi M, Cappagli B, De Simone L, Orlandi R, Genazzani AR. Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas. 2001;39:125–132
  4. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive leptin concentrations in normal-weight and obese women. N Engl J Med. 1996;334:292–295
  5. Ahima R, Osei S. Molecular regulation of eating behavior: new insights and prospects for therapeutic strategies. Trends Mol Med. 2001;7:205–213
  6. Di Carlo C, Tommaselli GA, Nappi C. Effects of sex steroid hormones and menopause on serum leptin concentrations. Gynecol Endocrinol. 2002;16:479–492
  7. Thomas T, Burguera B, Melton LJ, Atkinson EJ, O'Fallon WM, Riggs BL, et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism. 2000;49:1278–1284
  8. Hadji P, Hars O, Bock K, Sturm G, Bauer T, Emons G, et al. The influence of menopause and body mass index on serum leptin concentrations. Eur J Endocrinol. 2000;143:55–60
  9. Kanaley JA, Sames C, Swisher L, Swick AG, Ploutz-Snyder LL, Steppan CM, et al. Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism. 2001;50:976–982
  10. Kristensen K, Pedersen SB, Richelsen B. Interactions between sex steroid hormones and leptin in women. Studies in vivo and in vitro. Int J Obes Relat Metab Disord. 2000;24:1438–1444
  11. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. Gender differences in plasma leptin concentrations. Nat Med. 1996;2:949–950
  12. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in human and rodent: measurements of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med. 1995;1:1155–1161
  13. Hassink SG, Sheslow DV, de Lancey E, Opentanova I, Considine RV, Caro JF. Serum leptin in children with obesity: relationship to gender and development. Pediatrics. 1996;98:201–203
  14. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N, et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol. 1997;154:285–292
  15. Brann DW, De Sevilla L, Zamorano PL, Malesh VB. Regulation of leptin gene expression and secretion by steroid hormones. Steroids. 1999;64:659–663
  16. Machinal-Quelin F, Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine. 2002;18:179–184
  17. Espeland MA, Stefanick ML, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab. 1997;82:1549–1556
  18. Sorensen MB, Rosenfalck AM, Hojgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res. 2001;9:622–626
  19. Hassager C, Christiansen C. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metabolism. 1989;38:662–665
  20. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 1991;40:1323–1326
  21. Bartness TJ, Wade GN. Effects of interscapular brown adipose tissue denervation on body weight and energy metabolism in ovariectomized and estradiol-treated rats. Behav Neurosci. 1984;98:674–685
  22. Stern JJ, Murphy M. The effects of thyroxine and estradiol benzoate on wheel running activity in female rats. Physiol Behav. 1972;9:79–82
  23. Wade GN, Gray JM. Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol Behav. 1979;22:583–593
  24. Dagnault A, Ouerghi D, Richard D. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol. Brain Res Bull. 1993;32:689–692
  25. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Polonowski A. Relationship among leptin, neuropeptide Y, and galanin in young women and in postmenopausal women. Menopause. 2000;7:149–155
  26. Di Carlo C, Tommaselli GA, Pisano G, Nasti A, Rossi V, Palomba S, et al. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause. 2000;7:36–41
  27. Haffner SM, Mykkanen L, Stern MP. Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol. 1997;146:581–585
  28. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996;81:3424–3427
  29. Ayub N, Khan SR, Syed F. Leptin levels in pre and post menopausal Pakistani women. J Pak Med Assoc. 2006;56:3–5
  30. Hadji P, Gorke K, Hars O, Bauer T, Emons G, Schulz KD. The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women. Maturitas. 2000;37:105–111
  31. Konukoglu D, Serin O, Ercan M. Plasma leptin levels in obese and non-obese postmenopausal women before and after hormone replacement therapy. Maturitas. 2000;36:203–207
  32. Messinis IE, Kariotis I, Milingos S, Kollios G, Seferiadis K. Treatment of normal women with oestradiol plus progesterone prevents the decrease of leptin concentrations induced by ovariectomy. Hum Reprod. 2000;15:2383–2387
  33. Messinis IE, Papageorgiou I, Milingos S, Asprodini E, Kollios G, Seferiadis K. Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women. Hum Reprod. 2001;16:1827–1832
  34. Lavoie HB, Taylor AE, Sharpless JL, Anderson EJ, Strauss CC, Hall JE. Effects of short-term hormone replacement on serum leptin levels in postmenopausal women. Clin Endocrinol. 1999;5:415–422
  35. Cagnacci A, Malmusi S, Arangino S, Zanni A, Rovati L, Cagnacci P, et al. Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study. Menopause. 2002;9:65–71
  36. Wade GN, Gray JM. Cytoplasmic 17-beta [3H] estradiol binding in rat adipose tissues. Endocrinology. 1978;103:1695–1701
  37. Castracane VD, Kraemer RR, Franker MA, Kraemer GR, Gimpel T. Serum leptin concentration in women: effect of age, obesity, and estrogen administration. Fertil Steril. 1998;70:472–477
  38. Paolisso G, Rizzo MR, Mone CM, Tagliamonte MR, Gambardella A, Riondino M, et al. Plasma sex hormones are significantly associated with plasma leptin concentration in healthy subjects. Clin. Endocrinol. 1998;48:291–297
  39. Vettor R, De Pergola G, Pagano C, Englaro P, Laudadio E, Giorgino F, et al. Gender differences in serum leptin in obese people: relationship with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest. 1997;27:1016–1024
  40. Nagy TR, Davies SL, Hunter GR, Darnell B, Weinsier RL. Serum leptin concentrations and weight gain in obese postmenopausal women. Obes Res. 1998;6:257–261
  41. Auverix J, Staels B. Leptin. Lancet. 1999;351:737–742
  42. Ostlund RE, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age and metabolic covariates. J Clin Endocrinol Metab. 1996;81:3909–3913
  43. Kiran H, Kiran G, Ekerbicer HC, Kilinc M. Effects of intranasal estradiol treatment on serum lipoprotein(a) and lipids in hysterectomized women. Gynecol Obstet Invest. 2004;57:191–195
  44. Hemelaar M, Kenemans P, de Bie L, van de Weijer PH, van der Mooren MJ. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women. Fertil Steril. 2006;85:979–988
  45. Mattsson LA, Christiansen C, Colau JC, Palacios S, Kenemans P, Bergeron C, et al. Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms. Am J Obstet Gynecol. 2000;182:545–552
  46. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations analysis of studies published from 1974–2000. Fertil Steril. 2001;75:898–915
  47. Sitruk-Ware R. Progestins and cardiovascular risk markers. Steroids. 2000;65:651–658

PII: S0015-0282(06)04692-9

doi: 10.1016/j.fertnstert.2006.11.142

Fertility and Sterility
Volume 88, Issue 2 , Pages 383-389 , August 2007

Article Tools

* Image Usage & Resolution